Convergence Investment Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Convergence Investment Partners’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-24,409	Closed	-$917K	–	262
2020 Q2	$917K	Buy	24,409 +5,072	+26%	+$203K	0.32%	115
2020 Q1	$709K	Buy	+19,337	New	+$751K	0.31%	102
2019 Q1	–	Sell	-13,374	Closed	-$413K	–	356
2018 Q4	$413K	Buy	+13,374	New	+$488K	0.09%	208
2016 Q2	–	Sell	-38,884	Closed	-$2.08M	–	366
2016 Q1	$2.08M	Sell	38,884 -61,222	-61%	-$3.02M	0.25%	146
2015 Q4	$5.15M	Buy	+100,106	New	+$4.97M	0.58%	41

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Convergence Investment Partners's PBH Position: Q3 2020 in Review

Convergence Investment Partners sold out of Prestige Consumer Healthcare (PBH) in Q3 2020, closing a stake of 24,409 shares — an estimated $917K sold.

Convergence Investment Partners first reported a position in PBH in Q4 2015 and held it in 5 quarters. The position peaked at $5.15M in Q4 2015. 242 funds tracked by Wall St. Rank hold PBH as of Q3 2020.

Convergence Investment Partners reported no remaining Prestige Consumer Healthcare position as of Q3 2020 after selling out during the quarter.
Convergence Investment Partners sold 24,409 Prestige Consumer Healthcare shares in Q3 2020, an estimated $917K.
Convergence Investment Partners first reported a position in Prestige Consumer Healthcare in Q4 2015 and held it in 5 quarters.
Convergence Investment Partners's Prestige Consumer Healthcare position peaked at $5.15M in Q4 2015.
242 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2020.

Based on Convergence Investment Partners's 13F filing for Q3 2020, filed 28 Oct 2020.